These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 9694527
1. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Griebel G, Perrault G, Sanger DJ. Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527 [Abstract] [Full Text] [Related]
2. Pharmacological studies on synthetic flavonoids: comparison with diazepam. Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ. Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415 [Abstract] [Full Text] [Related]
3. Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. Kehne JH, Coverdale S, McCloskey TC, Hoffman DC, Cassella JV. Neuropharmacology; 2000 Jun 08; 39(8):1357-67. PubMed ID: 10818252 [Abstract] [Full Text] [Related]
4. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents. Griebel G, Perrault G, Soubrié P. Psychopharmacology (Berl); 2001 Nov 08; 158(3):241-51. PubMed ID: 11713613 [Abstract] [Full Text] [Related]
5. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists. Griebel G, Rodgers RJ, Perrault G, Sanger DJ. Psychopharmacology (Berl); 1999 May 08; 144(2):121-30. PubMed ID: 10394992 [Abstract] [Full Text] [Related]
6. CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours. Griebel G, Perrault G, Sanger DJ. Behav Pharmacol; 1997 Nov 08; 8(6-7):549-60. PubMed ID: 9832969 [Abstract] [Full Text] [Related]
7. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Griebel G, Perrault G, Sanger DJ. Neuropharmacology; 1997 Jun 08; 36(6):793-802. PubMed ID: 9225307 [Abstract] [Full Text] [Related]
8. Effects of SUN 8399, a potent and selective 5-HT1A agonist, on conflict behavior and ambulatory activity in mice: comparison with those of buspirone, tandospirone and diazepam. Kuribara H. Jpn J Pharmacol; 1994 Apr 08; 64(4):273-80. PubMed ID: 8057528 [Abstract] [Full Text] [Related]
9. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Griebel G, Rodgers RJ, Perrault G, Sanger DJ. Neuropharmacology; 2000 Jul 24; 39(10):1848-57. PubMed ID: 10884565 [Abstract] [Full Text] [Related]
11. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Fernández-Guasti A, Reyes R, Martínez-Mota L, López-Muñoz FJ. Psychopharmacology (Berl); 2005 Jul 24; 180(3):399-407. PubMed ID: 15719217 [Abstract] [Full Text] [Related]
12. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Griebel G, Belzung C, Perrault G, Sanger DJ. Psychopharmacology (Berl); 2000 Feb 24; 148(2):164-70. PubMed ID: 10663431 [Abstract] [Full Text] [Related]
13. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR. Br J Pharmacol; 1990 Feb 24; 99(2):343-9. PubMed ID: 1970269 [Abstract] [Full Text] [Related]
14. Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice. Griebel G, Perrault G, Sanger DJ. Pharmacol Biochem Behav; 1999 Apr 24; 62(4):689-94. PubMed ID: 10208374 [Abstract] [Full Text] [Related]
15. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P, Geslin M, Scatton B, Maffrand JP, Soubrié P. J Pharmacol Exp Ther; 2002 Apr 24; 301(1):333-45. PubMed ID: 11907191 [Abstract] [Full Text] [Related]
16. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models. Artaiz I, Romero G, Zazpe A, Monge A, Calderó JM, Roca J, Lasheras B, Del Río J. Psychopharmacology (Berl); 1995 Jan 24; 117(2):137-48. PubMed ID: 7753959 [Abstract] [Full Text] [Related]
17. Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone. Brodkin J, Busse C, Sukoff SJ, Varney MA. Pharmacol Biochem Behav; 2002 Sep 24; 73(2):359-66. PubMed ID: 12117590 [Abstract] [Full Text] [Related]
18. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Wada T, Fukuda N. Psychopharmacology (Berl); 1991 Sep 24; 104(4):444-50. PubMed ID: 1685794 [Abstract] [Full Text] [Related]
19. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ. J Pharmacol Exp Ther; 2000 Aug 24; 294(2):588-97. PubMed ID: 10900236 [Abstract] [Full Text] [Related]
20. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. J Pharmacol Exp Ther; 1997 Jul 24; 282(1):148-61. PubMed ID: 9223550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]